Leading biometrics CRO Phastar to share vast statistical expertise with biotechs working to build the drugs of the future

Press release graphic

London, UK and Durham, NC – January 23rd, 2024: Phastar, a global specialist biometrics contract research organization (CRO), has announced the launch of Stats Helpdesk, a new initiative designed to provide biotech companies with free access to its team of expert statisticians.

The Stats Helpdesk initiative offers essential support and guidance tailored to address the statistical questions and challenges facing biotech companies. Through a complimentary one-hour, no-obligation consultation, biotech companies can navigate intricate statistical landscapes, optimize study designs, and ensure the accuracy and reliability of their data analyses. The Stats Helpdesk also functions as a platform for fostering knowledge exchange, enabling biotech organizations to capitalize on the expertise offered by the Phastar team to enhance their statistical capabilities and improve their overall statistical proficiency, thereby supporting the progression of their projects and contributing to the broader growth of the biotech sector.

Continue Reading

Phastar Offers Pro Bono Support to Medicines Development for Global Health

Supporting medicine development for disadvantaged communities

London, UK, and Durham (NC), US – 26th October 2023: Phastar, a global specialist biometrics contract research organization (CRO) is offering pro bono support to Medicines Development for Global Health (MDGH), a not-for-profit organization developing medicines for neglected diseases primarily affecting people living in low- and middle-income countries.

As part of the Phastar Cares scheme, MDGH has pro bono access to the company’s biometrics experts as it conducts two large double-blind Phase IIIb clinical study at sites in the Democratic Republic of Congo and Cote d’Ivoire. One trial is evaluating the safety of moxidectin and the second is evaluating repeat single dosing compared with ivermectin in individuals living in onchocerciasis (river blindness) endemic areas.  

Graham Clark, CEO at Phastar, said: At Phastar, we have the expertise and the resources to make a meaningful difference and to deliver on our mission to improve human health. As a B CorpTM organization, we strive to be a force for good, and one of our strategic objectives is to lead the CRO industry in corporate social responsibility.

Continue Reading

Phastar Net-Zero Target Approved by the Science Based Targets Initiative

Phastar commits to achieving Net-Zero Standard by 2035

Phastar commits to achieving Net-Zero Standard by 2035

London, UK, and Durham (NC), US – 9th October 2023: Phastar, a global specialist biometrics contract research organization (CRO), has had its net-zero target approved by the Science Based Targets initiative (SBTi). The SBTi is a global body enabling businesses to set ambitious emissions reductions targets in line with the latest climate science and is considered the gold standard for net-zero.

A core component of Phastar’s commitment to SBTi is the ambitious pledge to achieve the Science Based Targets initiative (SBTi) Net-Zero Standard by 2035. By adopting stringent sustainability standards, Phastar aims to reduce its carbon footprint, engage with stakeholders, and promote responsible business practices.

Continue Reading

Phastar Appoints Graham Clark as New Chief Executive Officer

Image of Graham Clark, new CEO of Phastar

Phastar Sets Course for Further Growth with New CEO Appointment

London, UK and Durham (NC), US – 10th August 2023. Phastar, a global specialist biometrics contract research organization (CRO), today announced the appointment of Graham Clark as the new Chief Executive Officer. Amid ambitious growth plans and organizational changes, Clark will succeed Andrew MacGarvey as CEO and further boost the paradigm shift in delivery of world-class data quality oversight. Having positioned the company for success, MacGarvey will assume the Chief Operating Officer (COO) role, maintaining his Board position.

As former Managing Director with Phlexglobal, a global authority in Trial Master File (TMF) technology and services, Clark adds strong operational and commercial experience to the Phastar team. An accomplished leader with a proven track record in Operations, Strategy and Change management, he brings over 25 years’ experience in life sciences, financial, and professional services organizations.

Continue Reading

Phastar's B Corp™ certification affirms its status as a 'force for good' organisation

Image of B Corp certification

International certification recognizes leading global specialist biometrics CRO’s commitment and leadership in corporate social responsibility and sustainable business practices.

London, UK and Durham, NC – 11th July 2023.  Phastar, a global specialist biometrics contract research organization (CRO), have become a certified B Corporation®. It comes after a stringent 12-month review to ensure protocols and procedures reflect the company’s commitment to high environment, social, and governance (EGS) standards.

Certified B Corporations® (B Corps™) are for-profit companies that meet the highest standards of verified social and environmental performance, transparency, and legal accountability.  

As part of a rigorous process, the assessment body B Lab Global reviewed Phastar’s impact across the five key areas: governance, workers, environment, community, and customers. The minimum threshold for certification was 80 points, but Phastar achieved an impressive 91.4.

Continue Reading